Pancreatic Cancer Research

ResearcherNebraska Medical CenterActive in the last 2 years

Virender Kumar

Matched on ORCID iD 0000-0001-5353-5656; OpenAlex author ID A5101629632. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers

Papers 10

  1. Drug delivery and targeting to chemoresistant pancreatic cancer. Co-author DOI 10.1016/j.canlet.2024.216648↗
  2. Gemcitabine elaidate and ONC201 combination therapy for inhibiting pancreatic cancer in a KRAS mutated syngeneic mouse model. Co-author DOI 10.1038/s41420-024-01920-9↗
  3. Natural killer cells for pancreatic cancer immunotherapy: Role of nanoparticles. Co-author DOI 10.1016/j.canlet.2023.216462↗
  4. Nanoformulation design and therapeutic potential of a novel tubulin inhibitor in pancreatic cancer. First author DOI 10.1016/j.jconrel.2020.09.052↗
  5. Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy. First author DOI 10.1126/sciadv.abd6764↗
  6. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. Co-author DOI 10.1016/j.canlet.2017.05.007↗
  7. Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer. Co-author DOI 10.1038/s41598-017-01942-7↗
  8. EGFR-Targeted Polymeric Mixed Micelles Carrying Gemcitabine for Treating Pancreatic Cancer. First author DOI 10.1021/acs.biomac.5b01419↗
  9. Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer. Co-author DOI 10.1021/mp500847s↗
  10. miRNA profiling in pancreatic cancer and restoration of chemosensitivity. Co-author DOI 10.1016/j.canlet.2012.10.008↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ram I. Mahato · 10 shared papers, 2013–2024 · strength 1.72
  2. Goutam Mondal · 4 shared papers, 2015–2017 · strength 0.30
  3. Rajan Sharma Bhattarai · 2 shared papers, 2020–2021 · strength 0.25
  4. Vinod Kumar · 2 shared papers, 2017–2020 · strength 0.19
  5. Amit Chaudhary · 2 shared papers, 2017 · strength 0.16
  6. Wěi Li · 1 shared paper, 2021 · strength 0.13
  7. Tatiana K. Bronich · 1 shared paper, 2021 · strength 0.13
  8. Xiaofei Xin · 1 shared paper, 2020 · strength 0.12
  9. Krishna Kattel · 1 shared paper, 2017 · strength 0.09
  10. Pankaj Kumar Singh · 1 shared paper, 2016 · strength 0.08
  11. Surendra Kumar Shukla · 1 shared paper, 2016 · strength 0.08
  12. Surinder K. Batra · 1 shared paper, 2015 · strength 0.06
  13. Saurabh Pratap Singh · 1 shared paper, 2013 · strength 0.05
  14. Stephen W. Behrman · 1 shared paper, 2013 · strength 0.05
  15. Deepak Chitkara · 1 shared paper, 2013 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.